课题基金 / 基金详情

Ler a versatile global regulator from E. coli O157 and related strains

Ler a versatile global regulator from E. coli O157 and related strains
Ler 是来自大肠杆菌 O157 和相关菌株的多功能全局调节剂
批准号:
BB/E020860/1
负责人:
Mark Pallen
金额:
$59.12万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2007
资助国家:
英国
项目状态:
已结题
起止时间:
2007 至 --

项目摘要

项目成果

Mark Pallen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Already E. coli is generally a 'friendly bacterium', some kinds of E. coli, particularly E. coli O157, can cause severe gut infections in humans, posing a special threat to the very young and the very old. Infection is commonly associated with consumption of beef and related products (especially hamburgers), but can also result from consumption of contaminated vegetables or from farm visits. To gain a foothold in the human bowel, E. coli O157 uses a sophisticated molecular syringe (called a type III secretion system) to inject its own proteins into human cells. Deployment of the syringe is in turn controlled by regulation of the genes that encode its components. We are interested in a bacterial protein called Ler that regulates these type III secretion genes. Although interest in the past has focused exclusively on how Ler regulates type III secretion, we have preliminary evidence to suggest that Ler regulates many other facets of the bacterial cell. We now wish to confirm and expand on these findings to gain a global all-round view of Ler's function in gene regulation. We also wish to investigate Ler's interactions with other proteins and test our hypothesis that Ler is involved in a system for sensing when proteins are secreted and changing the expression of genes in response to such secretion. A better understanding of how Ler regulates virulence in E. coli will pave the way for the development and introduction of novel vaccine strains providing new approaches to the prevention and control not only of this fearsome pathogen, but also potentially of other infectious micro-organisms. In this work, we benefit from a (1) world-class team of applicants (all three have published in top journals such as Proceedings of the National Academy of Science in the last year), (2) an exceptional research environment with unique access to key technologies and information and (3) input from superb collaborators, who have broad experience of the kind of questions we are trying to address in other settings.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0080160
发表时间: 2014
期刊: PloS one
影响因子: 3.7
作者: [Bingle LE, Constantinidou C, Shaw RK, Islam MS, Patel M, Snyder LA, Lee DJ, Penn CW, Busby SJ, Pallen MJ]
通讯作者: Pallen MJ
CLIMB-BIG-DATA: A Cloud Infrastructure for Big-Data Microbial Bioinformatics
  • 批准号:
    MR/T030062/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $254.14万
  • 财政年份:
    2020
  • 负责人:
    Mark Pallen
  • 依托单位:
The MRC Consortium for Medical Microbial Bioinformatics
  • 批准号:
    MR/L015080/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $979.12万
  • 财政年份:
    2014
  • 负责人:
    Mark Pallen
  • 依托单位:
Acinetobacter baumannii: genomic profiling of an emerging hospital pathogen
  • 批准号:
    G0901717/2
  • 项目类别:
    Research Grant
  • 资助金额:
    $11.76万
  • 财政年份:
    2013
  • 负责人:
    Mark Pallen
  • 依托单位:
The chicken caecal microbiome: from baselines to biological impact
  • 批准号:
    BB/H019340/2
  • 项目类别:
    Research Grant
  • 资助金额:
    $13.69万
  • 财政年份:
    2013
  • 负责人:
    Mark Pallen
  • 依托单位:
海外基金